You are viewing the site in preview mode

Skip to main content

Table 3 Cox proportional hazard analysis of some factors of 28-day mortality following rTM treatment

From: Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study

Factors Adjusted OR 95% CI p value
Male 1.66 1.065–2.573 0.025
Age75 1.57 1.009–2.439 0.046
Sepsis-induced DIC 0.32 0.075–1.369 0.125
Solid tumor-induced DIC 0.54 0.096–3.057 0.487
Trauma-induced DIC 0.45 0.074–2.787 0.393
PT-INR1.67 2.23 1.451–3.433 < 0.001
rTM Dose380 U/kg 0.95 0.608–1.484 0.820
ATIII co-treatment 0.95 0.598–1.501 0.818
Treatment in ICU 0.91 0.595–1.380 0.645
  1. OR odds ratio, 95%CI 95% confidence interval
  2. ATIII antithrombin III, ICU intensive care unit, PT-INR prothrombin time-international normalized ratio